✦ LIBER ✦

A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL OF PALIPERIDONE ER VERSUS ORAL OLANZAPINE IN PATIENTS WITH SCHIZOPHRENIA

✍ Scribed by Andreas Schreiner; Peter Korcsog; D.J.H. Niehaus; Kaire Aadamsoo; Alp Ücok; Manuel Franco; P. Theodoropoulou; R. Salinas; Paul Bergmans; Dagmar Hoeben; Christophe Tessier

Book ID: 119365181
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 65 KB
Volume: 117
Category: Article
ISSN: 0920-9964
DOI: 10.1016/j.schres.2010.02.691

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.c.037 A prospective randomized contr

P.3.c.037 A prospective randomized controlled trial of paliperidone ER versus oral olanzapine in patients with schizophrenia

✍ C. Tessier; D. Hoeben; P. Korcsog; D.J.H. Niehaus; K. Aadamsoo; A. Ücok; M. Fran 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Effect of olanzapine orally disintegrati

Effect of olanzapine orally disintegrating tablet versus oral standard tablet on body weight in patients with schizophrenia: a randomized open-label trial

✍ Ichiro Kusumi; Minoru Honda; Keiichi Uemura; Yasuhumi Sugawara; Masako Kohsaka; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Comparison of metabolic changes in patie

Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long-acting injection versus oral olanzapine

✍ David P. McDonnell; Ludmila A. Kryzhanovskaya; Fangyi Zhao; Holland C. Detke; Pe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 1 views

Metabolic changes were examined in patients with schizophrenia during treatment with either oral olanzapine or olanzapine long‐acting injection (LAI). Data were collected from patients who had been stabilized on oral olanzapine (10, 15, or 20 mg/day) for ≥4 weeks and then randomized to either contin

Prospective, randomized, controlled tria

Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with “asymptomatic” primary hyperparathyroidism

✍ Nancy D. Perrier; Dave Balachandran; Jeffrey S. Wefel; Camilo Jimenez; Naifa Bus 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Olanzapine treatment for tardive dyskine

Olanzapine treatment for tardive dyskinesia in schizophrenia patients: a prospective clinical trial with patients randomized to blinded dose reduction periods

✍ Bruce J. Kinon; Dilip V. Jeste; Sara Kollack-Walker; Virginia Stauffer; Hong Liu 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 753 KB

A FLEXIBLE-DOSE STUDY OF PALIPERIDONE ER

A FLEXIBLE-DOSE STUDY OF PALIPERIDONE ER IN NON-ACUTE PATIENTS WITH SCHIZOPHRENIA PREVIOUSLY UNSUCCESSFULLY TREATED WITH ORAL RISPERIDONE

✍ Andreas Schreiner; Dagmar Hoeben; Marjolein Lahaye; Christophe Tessier; Theodore 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 65 KB